Aytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2024 Earnings Call Transcript September 26, 2024
Aytu BioPharma, Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.45.
Operator: Greetings, welcome to the Aytu BioPharma’s Fiscal 2024 Q4 Earnings Call. At this time, all participants have been placed on a listen-only mode. [Operator Instructions] Please note this conference is being recorded. I will now turn the conference over to your host, Robert Blum with Lytham...
